• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies.

作者信息

Gutierrez Daniel, Svigos Katerina, Femia Alisa, Brinster Nooshin K, Lo Sicco Kristen

机构信息

The Ronald O Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.

出版信息

JAAD Case Rep. 2022 Mar 3;22:107-109. doi: 10.1016/j.jdcr.2022.02.031. eCollection 2022 Apr.

DOI:10.1016/j.jdcr.2022.02.031
PMID:35355654
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8958465/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09fc/8958465/3771581dda76/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09fc/8958465/fb155150a32c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09fc/8958465/3771581dda76/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09fc/8958465/fb155150a32c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09fc/8958465/3771581dda76/gr2.jpg

相似文献

1
Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies.皮肌炎合并TIF1-γ自身抗体患者出现明显色素沉着异常。
JAAD Case Rep. 2022 Mar 3;22:107-109. doi: 10.1016/j.jdcr.2022.02.031. eCollection 2022 Apr.
2
Clinical significance of serum levels of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis.血清抗转录中介因子 1-γ 抗体水平在皮肌炎患者中的临床意义。
J Dermatol. 2020 May;47(5):490-496. doi: 10.1111/1346-8138.15284. Epub 2020 Feb 27.
3
Serum levels of anti-transcriptional intermediary factor 1-γ autoantibody associated with the clinical, pathological characteristics and outcomes of patients with dermatomyositis.与皮肌炎患者的临床、病理特征和结局相关的抗转录中介因子 1-γ 自身抗体的血清水平。
Semin Arthritis Rheum. 2022 Aug;55:152011. doi: 10.1016/j.semarthrit.2022.152011. Epub 2022 Apr 21.
4
Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.抗TIF1-α抗体阳性皮肌炎患者的临床特征与共存的皮肌炎特异性自身抗体以及抗TIF1-γ或抗Mi-2自身抗体密切相关。
Rheumatology (Oxford). 2012 Aug;51(8):1508-13. doi: 10.1093/rheumatology/kes073. Epub 2012 Apr 25.
5
Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence.针对 CCAR1 和其他皮肌炎自身抗原的免疫反应与癌症发生风险降低有关。
J Clin Invest. 2022 Jan 18;132(2). doi: 10.1172/JCI150201.
6
Identification of distinct cytokine/chemokine profiles in dermatomyositis with anti-transcriptional intermediary factor 1-γ antibody.抗转录中介因子1-γ抗体阳性皮肌炎中不同细胞因子/趋化因子谱的鉴定
Rheumatology (Oxford). 2022 May 5;61(5):2176-2184. doi: 10.1093/rheumatology/keab625.
7
Anti-transcriptional intermediary factor 1 gamma antibodies in cancer-associated myositis: a longitudinal study.癌症相关肌炎中抗转录中介因子 1γ 抗体：一项纵向研究。
Clin Exp Rheumatol. 2020 Jan-Feb;38(1):67-73. Epub 2019 Jul 30.
8
Anti-TIF1-γ autoantibodies: warning lights of a tumour autoantigen.抗 TIF1-γ 自身抗体：肿瘤自身抗原的警示灯。
Rheumatology (Oxford). 2020 Mar 1;59(3):469-477. doi: 10.1093/rheumatology/kez572.
9
Anti-transcriptional intermediary factor 1-γ antibody as a biomarker in patients with dermatomyositis.抗转录中介因子 1-γ 抗体作为皮肌炎患者的生物标志物。
J Dermatol. 2020 Jan;47(1):64-68. doi: 10.1111/1346-8138.15128. Epub 2019 Oct 22.
10
SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-γ, and Point Mutation in the Transcription Intermediary Factor 1-γ Coding Gene: A Case Report.小细胞肺癌、副肿瘤性皮肌炎、转录中介因子1-γ阳性及转录中介因子1-γ编码基因点突变：一例报告
JTO Clin Res Rep. 2021 Aug 9;2(9):100217. doi: 10.1016/j.jtocrr.2021.100217. eCollection 2021 Sep.

引用本文的文献

1
Multiple malignancy-associated dermatomyositis myositis-specific autoantibodies in dermatomyositis.皮肌炎中多种与恶性肿瘤相关的皮肌炎特异性自身抗体
JAAD Case Rep. 2025 Jun 16;62:134-135. doi: 10.1016/j.jdcr.2025.05.023. eCollection 2025 Aug.
2
Case report: "Fur stole and turtleneck" and "halter-back" signs: an expanded wardrobe for dermatomyositis.病例报告：“皮草披肩和高领衫”及“吊带背心”征：皮肌炎的扩展衣橱。
Front Immunol. 2024 Jun 5;15:1400575. doi: 10.3389/fimmu.2024.1400575. eCollection 2024.
3
My-Lupus: A case of anti-transcriptional intermediary factor 1-gamma antibody-positive  dermatomyositis overlapping with discoid lupus erythematosus in an adult patient.

本文引用的文献

1
The systemic management of cutaneous dermatomyositis: Results of a stepwise strategy.皮肤型皮肌炎的系统管理：逐步策略的结果
Int J Womens Dermatol. 2017 Jun 13;3(4):189-194. doi: 10.1016/j.ijwd.2017.05.001. eCollection 2017 Dec.
2
Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.成人皮肌炎中与抗转录中介因子-1γ抗体相关的独特皮肤和全身特征。
J Am Acad Dermatol. 2015 Mar;72(3):449-55. doi: 10.1016/j.jaad.2014.12.009. Epub 2015 Jan 14.
3
Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL).
我的狼疮病例：一名成年患者的抗转录中介因子1-γ抗体阳性皮肌炎合并盘状红斑狼疮
JAAD Case Rep. 2023 Sep 19;41:90-92. doi: 10.1016/j.jdcr.2023.09.002. eCollection 2023 Nov.
开发和验证一种白癜风特异性生活质量工具（VitiQoL）。
J Am Acad Dermatol. 2013 Jul;69(1):e11-8. doi: 10.1016/j.jaad.2012.01.038. Epub 2012 Feb 25.
4
Malignancy and myositis: novel autoantibodies and new insights.恶性肿瘤与肌炎：新型自身抗体与新见解。
Curr Opin Rheumatol. 2010 Nov;22(6):627-32. doi: 10.1097/BOR.0b013e32833f1075.
5
A pilot trial of rituximab in the treatment of patients with dermatomyositis.利妥昔单抗治疗皮肌炎患者的一项试点试验。
Arch Dermatol. 2007 Jun;143(6):763-7. doi: 10.1001/archderm.143.6.763.
6
A novel autoantibody to a 155-kd protein is associated with dermatomyositis.一种针对155千道尔顿蛋白的新型自身抗体与皮肌炎相关。
Arthritis Rheum. 2006 Nov;54(11):3682-9. doi: 10.1002/art.22164.
7
Increasing our understanding of pigmentary disorders.增进我们对色素沉着紊乱的了解。
J Am Acad Dermatol. 2006 May;54(5 Suppl 2):S255-61. doi: 10.1016/j.jaad.2005.12.042.